Log In
BCIQ
Print this Print this
 

PBF-509

  Manage Alerts
Collapse Summary General Information
Company Palobiofarma S.L.
DescriptionAdenosine A2A receptor (ADORA2A) antagonist
Molecular Target Adenosine A2A receptor (ADORA2A)
Mechanism of ActionAdenosine A2A receptor antagonist
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$15.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/21/2015

Undisclosed

$15.0M

Undisclosed

Get a free BioCentury trial today